Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2013 1
2014 1
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Results by year

Filters applied: . Clear all
Page 1
Second-line treatment trends and long-term outcomes of 392 children with chronic immune thrombocytopenic purpura: the French experience over the past 25 years.
Ducassou S, Gourdonneau A, Fernandes H, Leverger G, Pasquet M, Fouyssac F, Bayart S, Bertrand Y, Michel G, Jeziorski E, Thomas C, Abouchallah W, Viard F, Guitton C, Cheikh N, Pellier I, Carausu L, Droz C, Leblanc T, Aladjidi N; Centre de Référence National des Cytopénies Auto-immunes de l’Enfant (CEREVANCE). Ducassou S, et al. Br J Haematol. 2020 Jun;189(5):931-942. doi: 10.1111/bjh.16448. Epub 2020 Mar 4. Br J Haematol. 2020. PMID: 32130726 Free article.
Since 2004, patients less than 18 years old with cITP have been enrolled in the national prospective cohort, OBS'CEREVANCE. From 1990 to 2014, in 29 centres, 392 children were diagnosed with cITP. With a median follow-up of six years (2.0-25), 45% did not need second-line …
Since 2004, patients less than 18 years old with cITP have been enrolled in the national prospective cohort, OBS'CEREVANCE. From 1990 to 201 …
Romiplostim in children with chronic immune thrombocytopenia (ITP): the French experience.
Pasquet M, Aladjidi N, Guiton C, Courcoux MF, Munzer M, Auvrignon A, Lutz P, Ducassou S, Leroy G, Munzer C, Leverger G; Centre de Référence National des Cytopénies Auto-immunes de l'Enfant (CEREVANCE). Pasquet M, et al. Br J Haematol. 2014 Jan;164(2):266-71. doi: 10.1111/bjh.12609. Epub 2013 Oct 24. Br J Haematol. 2014. PMID: 24152194 Free article.
The long-term benefit/risk balance of this innovative treatment is currently recorded by Centre de Reference National des Cytopenies Auto-immunes de l'Enfant....
The long-term benefit/risk balance of this innovative treatment is currently recorded by Centre de Reference National des Cyto …
New insights into childhood autoimmune hemolytic anemia: a French national observational study of 265 children.
Aladjidi N, Leverger G, Leblanc T, Picat MQ, Michel G, Bertrand Y, Bader-Meunier B, Robert A, Nelken B, Gandemer V, Savel H, Stephan JL, Fouyssac F, Jeanpetit J, Thomas C, Rohrlich P, Baruchel A, Fischer A, Chêne G, Perel Y; Centre de Référence National des Cytopénies Auto-immunes de l'Enfant (CEREVANCE). Aladjidi N, et al. Haematologica. 2011 May;96(5):655-63. doi: 10.3324/haematol.2010.036053. Epub 2011 Jan 12. Haematologica. 2011. PMID: 21228033 Free PMC article.